Surgical and Oncological Outcomes in Patients With Ulcerative Colitis-associated Rectal Cancer
UC-RectalK
1 other identifier
observational
40
2 countries
2
Brief Summary
This is a retrospective observational study to investigate the short-term surgical outcomes, and long-term oncological outcomes of patients diagnosed with Ulcerative colitis and rectal cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2020
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2020
CompletedFirst Submitted
Initial submission to the registry
December 2, 2020
CompletedFirst Posted
Study publicly available on registry
December 9, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2021
CompletedDecember 9, 2020
December 1, 2020
4 months
December 2, 2020
December 2, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Surgical outcome
30 days postoperative complications
30 days after surgery
Oncological outcome
Disease-free survival
5 years after surgery
Interventions
Total proctocolectomy: surgical removal of the colon, rectum, and anus
Eligibility Criteria
The study will include adult patients with a proven diagnosis of Ulcerative Colitis and rectal adenocarcinoma, who underwent intestinal resection for curative intent, in elective or emergent setting, in the period between January 2004 and January 2020.
You may qualify if:
- Patients diagnosed with Ulcerative Colitis;
- Patients diagnosed with rectal cancer (within 15 cm from the anal verge);
- Patients who underwent surgery for rectal cancer between January 2004 and January 2020;
- All type of surgery will be included;
- Surgery in elective and emergency settings.
You may not qualify if:
- Patients aged\<18 years;
- Patients with a diagnosis of undetermined colitis;
- Insufficient follow-up data.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Humanitas Research Hospital
Rozzano, MI, 20089, Italy
St. Mark's Hospital
Harrow, HA1 3UJ, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Antonino Spinelli, MD, PhD
Istituto Clinico Humanitas
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 2, 2020
First Posted
December 9, 2020
Study Start
October 1, 2020
Primary Completion
January 30, 2021
Study Completion
April 1, 2021
Last Updated
December 9, 2020
Record last verified: 2020-12
Data Sharing
- IPD Sharing
- Will not share